Also trades as: XTLB.TA (TLV) · $vol 0M
XTLB NASDAQ
XTL Biopharmaceuticals Ltd.
1W: -1.8%
1M: -18.8%
3M: -31.2%
YTD: +260.3%
1Y: +87.8%
3Y: +109.7%
5Y: -47.5%
$2.16
+0.03 (+1.41%)
Weekly Expected Move ±9.6%
$2
$2
$2
$2
$3
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Balance Sheet Trends
Total Assets
$9M
+252.4% ▲
5Y CAGR: +3.5%
Total Liabilities
$3M
+1412.1% ▲
5Y CAGR: +68.1%
Shareholders Equity
$5M
+144.8% ▲
5Y CAGR: -4.9%
Cash & Investments
$1M
-43.0% ▼
5Y CAGR: -29.8%
Total Debt
$138K
+0.0% ▲
Net Debt
-$233K
+83.4% ▲
Assets vs Liabilities & Equity
Year-over-Year Growth
View Full Balance Sheet
| Line Item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| — Assets — | |||||
| Cash | $4M | $3M | $2M | $1M | $371K |
| Short-Term Investments | $2M | $3M | $2M | $605K | $772K |
| Cash & ST Investments | $6M | $6M | $4M | $2M | $1M |
| Net Receivables | $0 | $94K | $71K | $29K | $99K |
| Inventory | $0 | $0 | $0 | $0 | $0 |
| Other Current Assets | $13K | -$78K | -$57K | -$18K | $47K |
| Total Current Assets | $6M | $6M | $4M | $2M | $1M |
| Property, Plant & Equip. | $2K | $1K | $0 | $0 | $187K |
| Goodwill & Intangibles | $380K | $380K | $380K | $380K | $7M |
| Long-Term Investments | $0 | $0 | $0 | $0 | $14K |
| Other Non-Current Assets | $0 | $0 | $0 | $0 | $0 |
| Total Non-Current Assets | $382K | $381K | $380K | $380K | $7M |
| Total Assets | $7M | $7M | $4M | $2M | $9M |
| — Liabilities — | |||||
| Accounts Payable | $2K | $2K | $2K | $1K | $196K |
| Short-Term Debt | $0 | $0 | $0 | $0 | $138K |
| Deferred Revenue | $0 | $0 | $0 | $0 | $18K |
| Other Current Liabilities | $0 | $0 | $0 | $0 | $1M |
| Total Current Liabilities | $254K | $231K | $187K | $206K | $2M |
| Long-Term Debt | $0 | $0 | $0 | $0 | $0 |
| Other Non-Current Liab. | $3M | $1M | $0 | $0 | $689K |
| Total Non-Current Liabilities | $3M | $1M | $0 | $0 | $908K |
| Total Liabilities | $254K | $1M | $187K | $206K | $3M |
| — Equity — | |||||
| Common Stock | $13M | $14M | $14M | $14M | $23M |
| Retained Earnings | -$156M | -$155M | -$156M | -$158M | -$159M |
| Accumulated OCI | $20K | $20K | $20K | $20K | $20K |
| Total Stockholders Equity | $4M | $5M | $4M | $2M | $5M |
| Total Liabilities & Equity | $7M | $7M | $4M | $2M | $9M |
| — Key Metrics — | |||||
| Total Debt | $0 | $0 | $0 | $0 | $138K |
| Net Debt | -$4M | -$3M | -$2M | -$1M | -$233K |
| Total Investments | $2M | $3M | $2M | $605K | $786K |